Cyclic nucleotide-specific phosphodiesterases from Leishmania and uses thereof

Details for Australian Patent Application No. 2004270494 (hide)

Owner University of Bern Otsuka Pharmaceutical Co., Ltd.

Inventors Seebeck, Thomas; Johner, Andrea; Shakur, Yasmin

Agent Pizzeys

Pub. Number AU-B-2004270494

PCT Pub. Number WO2005/023856

Priority 60/582,584 25.06.04 US; 60/500,244 05.09.03 US; 60/504,070 19.09.03 US

Filing date 3 September 2004

Wipo publication date 17 March 2005

Acceptance publication date 14 October 2010

International Classifications

C07K 14/44 (2006.01) Peptides having more than 20 amino acids

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/023856 Priority application(s): WO2005/023856

14 October 2010 Application Accepted

  Published as AU-B-2004270494

10 February 2011 Standard Patent Sealed

29 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004270530-Method of separation/purification for high-purity silver chloride and process for producing high-purity silver by the same

2004270486